STSS Form 4: CFO Andrew Crescenzo Receives 40,000-Share Option

Rhea-AI Filing Summary

Andrew R. Crescenzo, who serves as Chief Financial Officer and a director of Sharps Technology Inc., was granted an option to purchase 40,000 shares on 08/22/2025 at an exercise price of $6.41 per share under the company's 2025 Equity Incentive Plan. The option is shown as directly beneficially owned for 40,000 shares following the grant and will become 100% vested and exercisable on May 22, 2026. The Form 4 was signed by Mr. Crescenzo on 08/26/2025. The filing lists the issuer as Sharps Technology Inc. (STSS).

Insights

Financial Analyst

TL;DR: A routine executive option grant of 40,000 shares at $6.41; standard time-based vesting to align management incentives.

The grant is a non-cash equity incentive that ties the CFO's compensation to future share performance without immediate dilution beyond potential exercise. The 100% vesting date (May 22, 2026) is time-based, which suggests retention rather than performance-contingent pay. No cash proceeds have been received yet and the filing shows direct beneficial ownership of the option for 40,000 shares following the grant. This disclosure is typical and not directly material to near-term financials.

Corporate Governance Expert

TL;DR: Governance practice appears standard: board-approved equity grant under the 2025 plan with single-date vesting.

The Form 4 indicates the company used its Equity Incentive Plan to grant an option to a named executive officer who is also a director, which raises standard oversight considerations but is common practice. The single-date, full vesting approach is straightforward; the filing contains no indication of related-party conflicts or special acceleration terms. Disclosure is complete for the reported transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Crescenzo Andrew R.

(Last) (First) (Middle)

C/O SHARPS TECHNOLOGY, INC.

105 MAXESS ROAD, STE. 124

(Street)

MELVILLE NY 11747

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Option (right to buy)	08/22/2025		P		40,000	A	$6.41	40,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Granted pursuant to the Company's 2025 Equity Incentive Plan. The option will become 100% vested and exercisable on May 22, 2026.

	/s/ Andrew Crescenzo	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Andrew R. Crescenzo report on Form 4 for Sharps Technology Inc. (STSS)?

He reported a grant of an option to purchase 40,000 shares on 08/22/2025 at an exercise price of $6.41 per share.

When does the granted option become exercisable?

The option will become 100% vested and exercisable on May 22, 2026.

How many shares does Crescenzo beneficially own following the transaction?

The filing shows 40,000 shares beneficially owned following the reported transaction.

Under what plan was the option granted?

The option was granted pursuant to the company's 2025 Equity Incentive Plan.

What roles does the reporting person hold at the company?

The form lists Andrew R. Crescenzo as a Director and Chief Financial Officer (Officer) of Sharps Technology Inc.